Emerging Research

Emerging Research

Will Hodgkin Lymphoma Patients Benefit From Checkpoint Inhibitors?

Do checkpoint inhibitors have a role in Hodgkin lymphoma care as a frontline treatment? Watach as Dr. Andrew Evens and Dr. Joshua Brody discuss the latest research developments, immunotherapy and more.

Joshua Brody, MD, Andrew Evens, DO, MSc, FACP, Andrew Schorr

Emerging Research

Treatment Developments and Ongoing Hodgkin Lymphoma Research

Expert Dr. John Burke discusses what’s new in the world of Hodgkin lymphoma. Watch now to learn about new studies on the use of radiation, how to treat early stage patients, and more.

Beth Kart Probert, John Burke, MD

Upcoming Events

See all events

Dec 7 2019

Saturday, December 7, 2019

ASH 2019 Daily Wraps

Join us for the first daily wrap to hear updates about the day's events from leading hematology experts.

Topic Area: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia , Chronic Lymphocytic Leukemia , Chronic Myelogenous Leukemia , Hodgkin Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Myeloproliferative Neoplasms, Non-Hodgkin Lymphoma

Time: 6:00 PM – 7:00 PM Eastern Time (US and Canada)

Latest News

Emerging Research

Immunotherapy for Hodgkin Lymphoma

Joshua Brody, MD, Esther Schorr, Andrew Evens, DO, MSc, FACP, Andrew Schorr

Emerging Research

Updates in Hodgkin Lymphoma from Dr. Burke

John Burke, MD

Emerging Research

Expert Updates in Hodgkin Lymphoma From ASH 2018

Radhakrishnan Ramchandren, MD

Find a clinical trial

Learn More